155 related articles for article (PubMed ID: 21406409)
41. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
42. Long-term thromboprophylaxis in practice: how can it be implemented?
Nurmohamed MT; MacGillavry MR
Orthopedics; 2000 Jun; 23(6 Suppl):s647-50. PubMed ID: 10875430
[TBL] [Abstract][Full Text] [Related]
43. Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.
Kuczka K; Harder S; Picard-Willems B; Warnke A; Donath F; Bianchini P; Parma B; Blume H
J Clin Pharmacol; 2008 Oct; 48(10):1189-96. PubMed ID: 18716314
[TBL] [Abstract][Full Text] [Related]
44. Production and chemical processing of low molecular weight heparins.
Linhardt RJ; Gunay NS
Semin Thromb Hemost; 1999; 25 Suppl 3():5-16. PubMed ID: 10549711
[TBL] [Abstract][Full Text] [Related]
45. Antithrombotics and anticoagulants in coronary syndromes and stroke.
Turpie AG
Semin Thromb Hemost; 2000; 26 Suppl 1():79-83. PubMed ID: 11011811
[TBL] [Abstract][Full Text] [Related]
46. Deep-vein thrombosis prophylaxis in orthopedic surgery: hip surgery.
Lassen MR; Backs S; Borris LC; Kaltoft-Sørenson M; Coff-Ganes H; Jeppesen E
Semin Thromb Hemost; 1999; 25 Suppl 3():79-82. PubMed ID: 10549720
[TBL] [Abstract][Full Text] [Related]
47. Are the current guidelines for the acceptance of generic low molecular weight heparins adequate?
Fareed J; Bick RL
Clin Appl Thromb Hemost; 2003 Oct; 9(4):269-72. PubMed ID: 14653436
[No Abstract] [Full Text] [Related]
48. Low molecular weight heparins copies: are they considered to be generics or biosimilars?
Minghetti P; Cilurzo F; Franzé S; Musazzi UM; Itri M
Drug Discov Today; 2013 Mar; 18(5-6):305-11. PubMed ID: 23153556
[TBL] [Abstract][Full Text] [Related]
49. Clinical experiences with low-molecular weight heparins in pediatric patients.
Hofmann S; Knoefler R; Lorenz N; Siegert G; Wendisch J; Mueller D; Taut-Sack H; Dinger J; Kabus M
Thromb Res; 2001 Sep; 103(5):345-53. PubMed ID: 11553367
[TBL] [Abstract][Full Text] [Related]
50. Market entry of biosimilar low-molecular-weight heparins in Europe: opportunities and challenges.
Simoens S; Huys I
Semin Thromb Hemost; 2013 Apr; 39(3):250-7. PubMed ID: 23235959
[TBL] [Abstract][Full Text] [Related]
51. Low molecular weight heparins: differences and similarities in approved preparations in the United States.
Bick RL; Fareed J
Clin Appl Thromb Hemost; 1999 Oct; 5 Suppl 1():S63-6. PubMed ID: 10726038
[TBL] [Abstract][Full Text] [Related]
52. Generic low molecular weight heparins: a significant dilemma.
Fareed J; Iqbal O; Nader H; Mousa S; Wahi R; Coyne E; Bick RL
Clin Appl Thromb Hemost; 2005 Oct; 11(4):363-6. PubMed ID: 16244760
[No Abstract] [Full Text] [Related]
53. Up close and personal with low-molecular-weight heparins (LMWHs).
Lugthart S
Neth J Med; 2015 Jul; 73(6):261-2. PubMed ID: 26228189
[No Abstract] [Full Text] [Related]
54. Survey of hospital policies regarding low-molecular-weight heparins.
Schumock GT; Nutescu EA; Walton SM; Arondekar BV; Lewis RK
Am J Health Syst Pharm; 2002 Mar; 59(6):534-8. PubMed ID: 11908246
[TBL] [Abstract][Full Text] [Related]
55. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With Enoxaparin.
Liu X; St Ange K; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Chi L; Jin C; Jin Y; Yao Y; Linhardt RJ
Clin Appl Thromb Hemost; 2017 Sep; 23(6):542-553. PubMed ID: 28056526
[TBL] [Abstract][Full Text] [Related]
56. Characterization of currently marketed heparin products: key tests for LMWH quality assurance.
Ye H; Toby TK; Sommers CD; Ghasriani H; Trehy ML; Ye W; Kolinski RE; Buhse LF; Al-Hakim A; Keire DA
J Pharm Biomed Anal; 2013 Nov; 85():99-107. PubMed ID: 23917037
[TBL] [Abstract][Full Text] [Related]
57. Analytical and statistical comparability of generic enoxaparins from the US market with the originator product.
Mourier PA; Agut C; Souaifi-Amara H; Herman F; Viskov C
J Pharm Biomed Anal; 2015 Nov; 115():431-42. PubMed ID: 26280926
[TBL] [Abstract][Full Text] [Related]
58. Low-molecular-weight heparin.
Wolf H
Med Clin North Am; 1994 May; 78(3):733-43. PubMed ID: 8170267
[TBL] [Abstract][Full Text] [Related]
59. Low molecular weight heparins. An objective overview.
Hoppensteadt D; Walenga JM; Fareed J
Drugs Aging; 1992; 2(5):406-22. PubMed ID: 1327312
[TBL] [Abstract][Full Text] [Related]
60. A need for evidence-based clinical practice guidelines for the use of heparins in the elderly.
Gouin-Thibault I; Siguret V; Pautas E
Clin Interv Aging; 2010 Apr; 5():119-21. PubMed ID: 20458349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
